Nawel Boukhatem with 13 years experience within the pharmaceutical industry in regulatory Affairs across 4 different regions Middle East, Egypt & South  Africa & North Africa. Nawel  is currently the Head of Regulatory Affairs for Middle East region and sitting in strategic discussion within ICMEA (India -Middle East-Maghreb, Egypt & South Africa, UCC & Turkey)  in Takeda pharmaceuticals  Company Limited (TSE:4502/NYSE:TAK) a global, values-based, R&D-driven biopharmaceutical leader with headquarters in Japan, committed to bringing better health and a brighter future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on the following therapeutic areas: Oncology, Gastroenterology, Rare Genetic & Hematology diseases, Neuroscience and globaly Plasma- Derived Therapies and Vaccines.

Before joining Takeda Pharmaceuticals company, Nawel was Regulatory Affairs Associate Director at Shire pharmaceuticals for Middle East and Africa before Takeda acquisition.

Prior Shire Nawel was regulatory affairs manager at Baxter pharmaceuticals for 3 years.

• She is a strong Regulatory Business Partner driver for results and a team player in any project she is part of it to enable different product launches and business expansion in fastest but in safer manner to help our patients across our countries to access to innovative products ; being energetic self-motivated person who spreads positive energy in any team she is part of;
• Nawel, inspires her colleagues and develop her team to perform at their best by building a positive work environment for talent development and growth, living their personal values in everything they did and giving back to patients.
• She enjoys working with diversed individuals from different cultures and disciplines including remote teams, learning new ideas and coaching others to address requirements from diverse stakeholder groups, including internal business partners, external suppliers and governmental organizations.
• Nawel sets high standard of results for her self and the team and succeeds to get their engagement and commitment.
• She has an excellent knowledge of pharma environment, regulations in Middle East and North Africa countries;